Development of a Hand-Held Cancer Biomarker Monitor
手持式癌症生物标志物监测仪的开发
基本信息
- 批准号:8127853
- 负责人:
- 金额:$ 18.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AmericanAntibodiesAntigensApoferritinBiologicalBiological AssayBiological MarkersBiopsyBiosensorBloodBlood specimenCancer DetectionCancer PatientCause of DeathClinicalColorectal CancerComplexCross ReactionsDeath RateDetectionDevelopmentDevicesDiagnosisDiagnostic Neoplasm StagingEnzyme-Linked Immunosorbent AssayEvaluationGoalsHandHealth PersonnelHeart DiseasesHumanImmobilizationImmunoassayLabelLaboratoriesLiquid substanceMagnetic Resonance ImagingMalignant NeoplasmsMalignant neoplasm of lungMammographyMeasurementMembraneMethodsModelingMolecular AnalysisMonitorPatientsPerformanceProteinsPublic HealthReactionReproducibilityResearchResearch Project GrantsSamplingScreening procedureSensitivity and SpecificitySignal TransductionSolutionsStagingTechniquesTechnologyTest ResultTestingTimeTransducersVendorbasecancer diagnosiscostdesignimmunoreactioninnovationinnovative technologiesinorganic phosphatemagnetic beadsmalignant breast neoplasmmammaglobinmultiplex detectionnanoparticlenew technologyprognosticpublic health relevancerapid detectionresponsetooltumor
项目摘要
DESCRIPTION (provided by applicant): The project will develop a Hand-Held cancer biomarker monitor based on imunochromatographic technology and nanoparticle based electrochemical immunoassay for rapid, sensitive, and low- cost detection of cancer biomarkers in human blood samples. Breast cancer biomarkers including carcinoenbryonic antigen (CEA), CA15-3 and human mammaglobin will be used as model biomarkers to demonstrate the proof of principle. The principle of the proposed device is based on nanoparticle-powered multiplex bioelectrochemical immunodetection and immunochromatographic separation technique. The multiplex capabilities and significant signal amplification of electrochemical immunoassay are realized conveniently by the use of multiple metallic phosphate nanoparticle labels. Integrating with immunochromatographic separation technology, the new biosensor microanalysis device will provide a portable, sensitive, simple, and low-cost tool for the rapid detection of multiple breast cancer biomarkers. The complete assay time will be less than 10 minutes and the detection limits are 10 times lower than the cutoff values. The device will be used to detect the samples from breast cancer patients and the results will be validated with traditional enzyme-linked immunosorbent assay (ELISA). If the project is successful, the proposed device will be an effective and innovative tool in aiding early cancer diagnosis, monitoring response to therapy and providing real-time prognostic information in patients with cancers. The developed device can also be applied for the detection of other cancer biomarkers.
PUBLIC HEALTH RELEVANCE: Cancer is a major and increasing public health problem worldwide. In US, it is the second leading cause of death, just behind heart disease. It is estimated around about 565,650 Americans are expected to die of cancer, more than 1,500 people a day (Cancer Facts and Figures, 2008). The key to decrease the death rate is to detect the cancers as early as possible. However, the majority of patients are diagnosed as having cancer at a late stage. For example, 72% of lung cancer patients, 57% of colorectal cancer patients, and 34% of breast cancer patients in the US are diagnosed at late stage. Traditionally, the diagnosis, screening and staging of cancer, as well as the evaluation of response to therapy have been primarily based on mammography, magnetic resonance imaging (MRI) and biopsy. These methods, although having a high detection rate, are expensive, time-consuming, invasive and uncomfortable, and have significant limitations for predicting a given tumor's potential for progression and response to treatment. There is, therefore, a need for an inexpensive, noninvasive, quick and simple tool with a high sensitivity and specificity for the detection of cancer biomarkers in aiding early cancer diagnosis, monitoring response to therapy and providing real-time prognostic information in patients with cancers. The proposed research for developing a hand-held cancer biomarker monitor is greatly needed for rapid, sensitive, low- cost, and multiplex detection of cancer biomarkers in human blood. Breast cancer biomarkers including carcinoenbryonic antigen (CEA), CA15-3 and human mammaglobin (HMAM) will be used as models to demonstrate the proof of principle. If the project is successful, the developed device can also be applied for the noninvasive monitoring of other tumor biomarkers in biological fluids such as blood.
项目描述(由申请人提供):该项目将开发一种基于免疫层析技术和纳米粒子电化学免疫分析的手持式癌症生物标志物监测仪,用于快速、灵敏、低成本地检测人类血液样本中的癌症生物标志物。包括癌胚抗原(CEA)、CA15-3和人乳蛋白在内的乳腺癌生物标志物将被用作模型生物标志物来证明原理。该装置的原理是基于纳米粒子驱动的多重生物电化学免疫检测和免疫层析分离技术。利用多个金属磷酸盐纳米颗粒标记,方便地实现了电化学免疫分析的多重功能和显著的信号放大。结合免疫层析分离技术,新型生物传感器微分析装置将为多种乳腺癌生物标志物的快速检测提供一种便携、灵敏、简单、低成本的工具。整个分析时间将少于10分钟,检出限比截止值低10倍。该装置将用于检测乳腺癌患者的样本,并将用传统的酶联免疫吸附试验(ELISA)验证结果。如果该项目成功,该装置将成为帮助癌症早期诊断、监测治疗反应和为癌症患者提供实时预后信息的有效创新工具。该装置还可用于其他癌症生物标志物的检测。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Visual detection of single-base mismatches in DNA using hairpin oligonucleotide with double-target DNA binding sequences and gold nanoparticles.
- DOI:10.1016/j.bios.2011.12.055
- 发表时间:2012-04-15
- 期刊:
- 影响因子:12.6
- 作者:He, Yuqing;Zhang, Xibao;Zhang, Sanquan;Kris, Mak Ka Long;Man, Fong Chi;Kawde, Abdel-Nasser;Liu, Guodong
- 通讯作者:Liu, Guodong
Simultaneous detection of nucleic acid and protein using gold nanoparticles and lateral flow device.
使用金纳米颗粒和侧流装置同时检测核酸和蛋白质
- DOI:10.2116/analsci.30.637
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Mao X;Gurung A;Xu H;Baloda M;He Y;Liu G
- 通讯作者:Liu G
Gold-nanoparticle-decorated silica nanorods for sensitive visual detection of proteins.
- DOI:10.1021/ac502249f
- 发表时间:2014-08-05
- 期刊:
- 影响因子:7.4
- 作者:Xu, Hui;Chen, Jiao;Birrenkott, Joseph;Zhao, Julia Xiaojun;Takalkar, Sunitha;Baryeh, Kwaku;Liu, Guodong
- 通讯作者:Liu, Guodong
Visual detection of microRNA with lateral flow nucleic acid biosensor.
- DOI:10.1016/j.bios.2013.10.055
- 发表时间:2014-04-15
- 期刊:
- 影响因子:12.6
- 作者:Gao, Xuefei;Xu, Hui;Baloda, Meenu;Gurung, Anant S.;Xu, Li-Ping;Wang, Tao;Zhang, Xueji;Liu, Guodong
- 通讯作者:Liu, Guodong
Recent trends in SELEX technique and its application to food safety monitoring.
- DOI:10.1007/s00604-013-1156-7
- 发表时间:2014-04
- 期刊:
- 影响因子:5.7
- 作者:Wu, Jingjing;Zhu, Yingyue;Xue, Feng;Mei, Zhanlong;Yao, Li;Wang, Xin;Zheng, Lei;Liu, Jian;Liu, Guodong;Peng, Chifang;Chen, Wei
- 通讯作者:Chen, Wei
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guodong Liu其他文献
Guodong Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guodong Liu', 18)}}的其他基金
The interplay of behavioral therapies, pharmacological treatments and psychiatric adverse events among Youth with Autism Spectrum Disorders
患有自闭症谱系障碍的青少年的行为疗法、药物治疗和精神不良事件之间的相互作用
- 批准号:
10655048 - 财政年份:2023
- 资助金额:
$ 18.17万 - 项目类别:
Identifying Early Markers of Autism Spectrum Disorder Based on Patterns of Medical Symptoms and Healthcare Service
根据医疗症状和医疗服务模式识别自闭症谱系障碍的早期标志
- 批准号:
9895898 - 财政年份:2020
- 资助金额:
$ 18.17万 - 项目类别:
Nanoparticle-Powered Chemiluminescent Lateral Flow Biosensor Array for Early Diagnosis of Pancreatic Cancer
纳米颗粒驱动的化学发光侧流生物传感器阵列用于胰腺癌的早期诊断
- 批准号:
8813061 - 财政年份:2016
- 资助金额:
$ 18.17万 - 项目类别:
Development of a Hand-Held Cancer Biomarker Monitor
手持式癌症生物标志物监测仪的开发
- 批准号:
7871157 - 财政年份:2010
- 资助金额:
$ 18.17万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 18.17万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 18.17万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 18.17万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 18.17万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 18.17万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 18.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 18.17万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 18.17万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 18.17万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 18.17万 - 项目类别:
Standard Grant